杂志文章%@ 1438-8871 %I JMIR Publicatio卡塔尔世界杯8强波胆分析ns Inc. %V 17 %N 7 %P e171% T不良药物反应识别和提取在社交媒体:范围审查%肥腊肉片,杰里米·% Abdellaoui, Redhouane %•贝雷特如是,Florelle % Asfari, Hadyl % Souvignet,朱利安% Texier,娜塔莉% Jaulent,玛丽- % Beyens, Marie-Noelle % Burgun,安妮塔% Bousquet,塞德里克% +巴黎13日巴黎索邦神学院引用,Laboratoire d 'Informatique医学et d 'Ingenieurie des Connaissances en e-Sante (LIMICS),(联合Mixte de矫揉造作的桑特,UMR_S 1142), f - 93430, Villetaneuse,法国,巴黎索邦大学,皮埃尔和玛丽居里大学(UPMC)巴黎06,团结Mixte de矫揉造作的en桑特(UMR_S) 1142年,Laboratoire d 'Informatique医学et d 'Ingenieurie des Connaissances en e-Sante (LIMICS), f - 75006,国家卫生研究所et de la医学研究院(INSERM) U1142, Laboratoire d 'Informatique医学et d 'Ingenieurie des Connaissances en e-Sante (LIMICS), f - 75006,校园des Cordeliers,法国巴黎国家研究院Santé和研究中心Médicale (INSERM) U 1142 -信息实验室Médicale et d'Ingénieurie des connaisissances en e-Santé (LIMICS) Esc d - 2ème étage, 15 rue de l’École de Médecine，巴黎，75006，法国，33 144279190，jeremy.lardon@chu-st-etienne.fr %K药物警戒%K药物不良反应%K互联网%K Web 2.0 %K社交媒体%K文本挖掘%K范围审查%K不良事件%D 2015 %7 10.07.2015 %9审查%J J医学互联网Res %G英文%X背景:通过传统报告渠道对药物不良反应(ADRs)报告不足是当前药物警戒体系效率的一个限制。患者在社交媒体上报告的用药经历代表了一种新的数据来源，可能对上市后的安全监测有一定价值。目的:进行范围审查，以探索关于使用社交媒体作为药物警戒的新知识来源的证据的广度。方法:遵循Daubt等人对范围审查的建议。研究问题如下:如何利用社交媒体作为药物上市后监测的数据源?有哪些提取数据的方法? What are the different ways to use these data? We queried PubMed, Embase, and Google Scholar to extract relevant articles that were published before June 2014 and with no lower date limit. Two pairs of reviewers independently screened the selected studies and proposed two themes of review: manual ADR identification (theme 1) and automated ADR extraction from social media (theme 2). Descriptive characteristics were collected from the publications to create a database for themes 1 and 2. Results: Of the 1032 citations from PubMed and Embase, 11 were relevant to the research question. An additional 13 citations were added after further research on the Internet and in reference lists. Themes 1 and 2 explored 11 and 13 articles, respectively. Ways of approaching the use of social media as a pharmacovigilance data source were identified. Conclusions: This scoping review noted multiple methods for identifying target data, extracting them, and evaluating the quality of medical information from social media. It also showed some remaining gaps in the field. Studies related to the identification theme usually failed to accurately assess the completeness, quality, and reliability of the data that were analyzed from social media. Regarding extraction, no study proposed a generic approach to easily adding a new site or data source. Additional studies are required to precisely determine the role of social media in the pharmacovigilance system. %M 26163365 %R 10.2196/jmir.4304 %U //www.mybigtv.com/2015/7/e171/ %U https://doi.org/10.2196/jmir.4304 %U http://www.ncbi.nlm.nih.gov/pubmed/26163365